[BLACKSBURG, USA – May 13th, 2025] – The animal organ transplant industry is achieving unprecedented success, according to a new 320-page ClearView Market Insights report. The market is projected to grow at a 32.9% CAGR, reaching USD 7.5 billion by 2031, thus extending pets' lives by years.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-animal-organ-transplant-market/
Key Industry Shifts
- Clinical Breakthroughs
- Revivicor's Pig Kidneys:
- Function normally in 90% of dogs at 1 year
- Organovo's Bioprinted Livers:
- Process toxins at 85% native organ capacity
- Economic Accessibility
- Cost Reductions:
- Dropped from 150K to 150K to 45K per transplant
- Insurance Adoption:
- Trupanion now covers 50% of procedures
- Genetic Matching
- AKC Genome Project:
- Matches donors to recipients with 95% compatibility
- Feline DNA Registry:
- 100K cats sequenced for transplant optimization
Executive Insights
- David Ayares, Revivicor CEO:
"Our gene-edited pig organs function better than dialysis in dogs." - Dr. Sharon Presnell, Organovo:
"Bioprinting livers from a pet's own cells eliminates rejection."
Future Projections
- 2028: First commercial bioprinted liver
- 2030: 50% feline HCM cases treated with transplants
- 2032: Livestock cloning becomes donor supply solution
For more insights, visit https://clearviewmarketinsights.com/
About ClearView Market Insights
ClearView Market Insights is a globally recognized research firm specializing in industrial automation, logistics, and smart manufacturing. Our reports provide data-driven insights to help businesses navigate evolving markets.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
